| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2014 | US20140017219 Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline |
| 01/16/2014 | US20140017216 Pesticidal mixtures |
| 01/16/2014 | US20140017204 Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity |
| 01/16/2014 | US20140017202 Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity |
| 01/16/2014 | US20140017199 Modulators of pharmacokinetic properties of therapeutics |
| 01/16/2014 | US20140017198 Inhibitors of hepatitis c virus |
| 01/16/2014 | US20140017196 Compositions and methods of use of phorbol esters |
| 01/16/2014 | US20140017195 Hepatitis C Virus Inhibitors |
| 01/16/2014 | US20140017194 Compositions And Methods Of Use Of Phorbol Esters |
| 01/16/2014 | US20140017192 Pharmaceutical composition containing block copolymer comprising boric acid compound |
| 01/16/2014 | US20140017178 Blue Curls "Pirzada" and Related Compositions and Methods |
| 01/16/2014 | US20140017175 Pentablock polymers |
| 01/16/2014 | US20140017172 Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 01/16/2014 | US20140017165 Dna repair enzyme inhibitor nanoparticles and uses thereof |
| 01/16/2014 | DE202013104575U1 Mischung aus mikrogekapselten Aminosäuren Microencapsulated blend of amino acids |
| 01/16/2014 | DE202011110392U1 Oral verabreichbare pharmazeutische Zusammensetzung zur behandlung von Menstruationsschmerzen, die von übermäßigem menstruellem Blutverlust begleitet sind Orally administrable pharmaceutical composition for the treatment of menstrual cramps, which are accompanied by excessive menstrual blood loss |
| 01/16/2014 | DE102012006903A9 Neue aromatische Heterocyclen, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend neue aromatische Heterocyclen New aromatic heterocycles, to processes for their preparation and medicines containing novel aromatic heterocycles |
| 01/16/2014 | DE10121375B4 Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut Use of isoflavonoids in cosmetic or dermatological preparations for the prophylaxis against and treatment of sensitive skin |
| 01/16/2014 | CA2877550A1 Imidazopyridine derivatives as modulators of tnf activity |
| 01/16/2014 | CA2877543A1 Imidazopyrazine derivatives as modulators of tnf activity |
| 01/16/2014 | CA2877445A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 01/16/2014 | CA2877187A1 Antiproliferative benzo [b]azepin-2-ones |
| 01/16/2014 | CA2876884A1 Crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof |
| 01/16/2014 | CA2876528A1 Solid maple syrup compositions |
| 01/16/2014 | CA2876370A1 Compounds and methods for treating hiv |
| 01/16/2014 | CA2876021A1 Stabilized multi-functional antioxidant compounds and methods of use |
| 01/16/2014 | CA2875057A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/16/2014 | CA2862301A1 Compositions and methods of use of phorbol esters for the treatment of stroke |
| 01/15/2014 | EP2684957A2 Double-stranded siRNA targeting cancer antigen eEF2 |
| 01/15/2014 | EP2684885A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
| 01/15/2014 | EP2684884A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
| 01/15/2014 | EP2684883A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
| 01/15/2014 | EP2684882A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
| 01/15/2014 | EP2684880A1 Dispiropyrrolidine derivative |
| 01/15/2014 | EP2684879A1 Substituted mesoionic compounds for combating animal pests |
| 01/15/2014 | EP2684878A1 Dipyridylamine derivative |
| 01/15/2014 | EP2684877A2 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof |
| 01/15/2014 | EP2684874A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors |
| 01/15/2014 | EP2684873A1 Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/15/2014 | EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 01/15/2014 | EP2684866A1 Compound and method for producing same, as well as method for producing oseltamivir phosphate |
| 01/15/2014 | EP2684861A2 Spiro compounds and pharmaceutical use thereof |
| 01/15/2014 | EP2684574A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 01/15/2014 | EP2684573A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 01/15/2014 | EP2684565A1 Use of ulipristal acetate for treating uterine fibroids |
| 01/15/2014 | EP2684564A1 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation |
| 01/15/2014 | EP2684563A1 Antibacterial or preserving composition containing 3-butoxy-1,2-propanediol |
| 01/15/2014 | EP2684466A2 Method for producing cultured root of purple ginseng |
| 01/15/2014 | EP2684456A1 Fungicidal and bactericidal composition that comprises volatile organic compounds of natural origin |
| 01/15/2014 | EP2683826A2 Use of aptamers in therapy and/or diagnosis of autoimmune diseases |
| 01/15/2014 | EP2683825A1 Methods of treating cancer by inhibition of dna repair proteins |
| 01/15/2014 | EP2683823A1 Molecular targets for healing or treating wounds |
| 01/15/2014 | EP2683746A1 Oligosaccharide compounds |
| 01/15/2014 | EP2683737A1 Extracellular targeted drug conjugates |
| 01/15/2014 | EP2683722A1 Fluorophenyl bicyclic heteroaryl compounds |
| 01/15/2014 | EP2683721A1 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
| 01/15/2014 | EP2683720A1 1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES |
| 01/15/2014 | EP2683719A1 SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| 01/15/2014 | EP2683717A1 Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[ 1, 2-a]-pyrimidin-4-one (paliperidone) and paliperidone palmitate. |
| 01/15/2014 | EP2683716A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors |
| 01/15/2014 | EP2683715A1 Pyrido [2, 3 - b]pyrazine derivatives and their therapeutical uses |
| 01/15/2014 | EP2683711A1 New pyridazinone and pyridone compounds |
| 01/15/2014 | EP2683710A1 Soluble guanylate cyclase activators |
| 01/15/2014 | EP2683709A1 Pyridinyl- and pyrazinyl -methyloxy - aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
| 01/15/2014 | EP2683708A1 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
| 01/15/2014 | EP2683706A1 Oxaspiro [2.5]octane derivatives and analogs |
| 01/15/2014 | EP2683705A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| 01/15/2014 | EP2683704A1 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| 01/15/2014 | EP2683703A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| 01/15/2014 | EP2683702A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| 01/15/2014 | EP2683701A1 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| 01/15/2014 | EP2683700A1 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| 01/15/2014 | EP2683699A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| 01/15/2014 | EP2683698A1 Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof |
| 01/15/2014 | EP2683697A1 Substituted morpholines as modulators for the calcium sensing receptor |
| 01/15/2014 | EP2683694A1 Androgen receptor antagonists and uses thereof |
| 01/15/2014 | EP2683693A1 Rorgammat inhibitors |
| 01/15/2014 | EP2683690A1 Quinolinone derivatives |
| 01/15/2014 | EP2683689A1 Fluoro-pyridinone derivatives useful as antibacterial agents |
| 01/15/2014 | EP2683687A1 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/15/2014 | EP2683444A1 Tfeb phosphorylation inhibitors and uses thereof |
| 01/15/2014 | EP2683412A2 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs |
| 01/15/2014 | EP2683388A2 Vaccine formulation of mannose coated peptide particles |
| 01/15/2014 | EP2683387A1 MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER |
| 01/15/2014 | EP2683386A2 Compounds and methods of use in ablative radiotherapy |
| 01/15/2014 | EP2683385A1 2,4 substituted pyrimidinediamines for use in discoid lupus |
| 01/15/2014 | EP2683384A1 Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione |
| 01/15/2014 | EP2683383A1 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2-6-dione in treatment of immune-related and inflammatory diseases |
| 01/15/2014 | EP2683382A2 Dosing regimens for the treatment of fabry disease |
| 01/15/2014 | EP2683381A1 Formulation comprising phenylaminopyrimidine derivative as active agent |
| 01/15/2014 | EP2683380A2 Heavy-duty vehicle brake assembly with sealing interface |
| 01/15/2014 | EP2683379A2 Substituted n-aryl pyridinones |
| 01/15/2014 | EP2683378A2 Amorphous form of lopinavir and ritonavir mixture |
| 01/15/2014 | EP2683377A1 Combination therapies for hematologic malignancies |
| 01/15/2014 | EP2683376A2 Methods for treating diseases using isoindoline compounds |
| 01/15/2014 | EP2683375A1 Colonoscopy - preparation |
| 01/15/2014 | EP2683374A1 Use of vanadium compounds for maintaining normaglycemia in a mammal |
| 01/15/2014 | EP2683373A1 Orthomolecular agent for countering the consequences of alcohol consumption |
| 01/15/2014 | EP2683372A1 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia |
| 01/15/2014 | EP2683371A1 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors |